These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2672842)

  • 1. Medical dissolution of gallstones by oral bile acid therapy.
    Hofmann AF
    Am J Surg; 1989 Sep; 158(3):198-204. PubMed ID: 2672842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
    Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
    Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodiol: a cholesterol gallstone solubilizing agent.
    Rosenbaum CL; Cluxton RJ
    Drug Intell Clin Pharm; 1988 Dec; 22(12):941-5. PubMed ID: 3072172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
    Podda M; Zuin M; Battezzati PM; Ghezzi C; de Fazio C; Dioguardi ML
    Gastroenterology; 1989 Jan; 96(1):222-9. PubMed ID: 2642440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol gallstone disease: the current status of nonsurgical therapy.
    Bilhartz LE
    Am J Med Sci; 1988 Jul; 296(1):45-56. PubMed ID: 3044106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid.
    Salen G
    J Clin Gastroenterol; 1988; 10 Suppl 2():S12-7. PubMed ID: 3062079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
    Grundy SM; Lan SP; Lachin J
    J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids.
    Senior JR; Johnson MF; DeTurck DM; Bazzoli F; Roda E
    Gastroenterology; 1990 Jul; 99(1):243-51. PubMed ID: 2344929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallstone dissolution therapy with ursodiol. Efficacy and safety.
    Salen G
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):39S-43S. PubMed ID: 2689115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstone dissolution with oral bile acid therapy. Importance of pretreatment CT scanning and reasons for nonresponse.
    Pereira SP; Veysey MJ; Kennedy C; Hussaini SH; Murphy GM; Dowling RH
    Dig Dis Sci; 1997 Aug; 42(8):1775-82. PubMed ID: 9286247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of cholesterol gallstones.
    Abate MA
    Drug Intell Clin Pharm; 1986 Feb; 20(2):106-15. PubMed ID: 3512222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallstone disappearance after extracorporeal lithotripsy and oral bile acid dissolution.
    Ponchon T; Barkun AN; Pujol B; Mestas JL; Lambert R
    Gastroenterology; 1989 Aug; 97(2):457-63. PubMed ID: 2744359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
    Fromm H
    J Clin Gastroenterol; 1988; 10 Suppl 2():S18-21. PubMed ID: 3062080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral dissolvents and extracorporeal lithotripsy: respective role and modalities of application].
    Erlinger S
    Rev Prat; 1992 Jun; 42(12):1487-9. PubMed ID: 1411171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gall stone dissolving agents.
    Bouchier IA
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):778-80. PubMed ID: 6402249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallstone dissolution therapy with ursodiol. Patient selection.
    Fromm H
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):36S-38S. PubMed ID: 2598766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
    Erlinger S
    Ann Chir; 1989; 43(6):417-9. PubMed ID: 2817740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.